BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23400628)

  • 1. Associations of Lys939Gln and Ala499Val polymorphisms of the XPC gene with cancer susceptibility: a meta-analysis.
    He J; Shi TY; Zhu ML; Wang MY; Li QX; Wei QY
    Int J Cancer; 2013 Oct; 133(8):1765-75. PubMed ID: 23400628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between polymorphisms of the XPC gene and lung cancer susceptibility: a meta-analysis.
    Zhu ML; Hua RX; Zheng L
    Tumour Biol; 2014 Apr; 35(4):2931-9. PubMed ID: 24375193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. XPC polymorphisms play a role in tissue-specific carcinogenesis: a meta-analysis.
    Francisco G; Menezes PR; Eluf-Neto J; Chammas R
    Eur J Hum Genet; 2008 Jun; 16(6):724-34. PubMed ID: 18285822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current evidences on XPC polymorphisms and breast cancer susceptibility: a meta-analysis.
    Zheng W; Cong XF; Cai WH; Yang S; Mao C; Zou HW
    Breast Cancer Res Treat; 2011 Aug; 128(3):811-5. PubMed ID: 21318603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. XPC Lys939Gln and Ala499Val polymorphisms in colorectal cancer susceptibility: a meta-analysis of case-control studies.
    Liu C; Yin Q; Ying M; Lin J; Li L; Jiao G; Wang M; Wang Y
    Mol Biol Rep; 2014 Feb; 41(2):1171-8. PubMed ID: 24385304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. XPC gene polymorphisms contribute to bladder cancer susceptibility: a meta-analysis.
    Dai QS; Hua RX; Zeng RF; Long JT; Peng ZW
    Tumour Biol; 2014 Jan; 35(1):447-53. PubMed ID: 23918308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of DNA repair gene XPC Ala499Val (rs2228000 C>T) and Lys939Gln (rs2228001 A>C) polymorphisms with the risk of chronic myeloid leukemia: A case-control study in a South Indian population.
    Lakkireddy S; Aula S; Kapley A; Gundeti S; Kutala VK; Jamil K
    J Gene Med; 2021 Jul; 23(7):e3339. PubMed ID: 33829606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
    Zhou RM; Li Y; Wang N; Zhang XJ; Dong XJ; Guo W
    Ai Zheng; 2006 Sep; 25(9):1113-9. PubMed ID: 16965652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between XPC polymorphisms and risk of cancers: A meta-analysis.
    Qiu L; Wang Z; Shi X; Wang Z
    Eur J Cancer; 2008 Oct; 44(15):2241-53. PubMed ID: 18771913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. XPC Lys939Gln polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.
    Peng Q; Lao X; Tang W; Chen Z; Li R; Qin X; Li S
    Diagn Pathol; 2014 Jun; 9():120. PubMed ID: 24947936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of XPC Polymorphisms with Cutaneous Malignant Melanoma Risk: Evidence from a Meta-Analysis.
    Asadian F; Niktabar SM; Ghelmani Y; Kargar S; Akbarian E; Emarati SA; Sadeghizadeh-Yazdi J; Neamatzadeh H
    Acta Medica (Hradec Kralove); 2020; 63(3):101-112. PubMed ID: 33002396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in the XPC gene affect urinary bladder cancer risk: a case-control study, meta-analyses and trial sequential analyses.
    Sankhwar M; Sankhwar SN; Bansal SK; Gupta G; Rajender S
    Sci Rep; 2016 Jun; 6():27018. PubMed ID: 27246180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between cigarette smoking and XPC-PAT genetic polymorphism enhance bladder cancer risk.
    Liu Y; Wang H; Lin T; Wei Q; Zhi Y; Yuan F; Song B; Yang J; Chen Z
    Oncol Rep; 2012 Jul; 28(1):337-45. PubMed ID: 22505326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of associations between XPC polymorphisms and colorectal cancer: a meta-analysis.
    Wang G; Sun H; Liu Z; Huang R; Chen Y; Tang Q; Yu L; Jiang Z; Wang X
    J BUON; 2015; 20(3):770-4. PubMed ID: 26214629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association of XPC and XPG polymorphisms with the risk of hepatocellular carcinoma].
    Li LM; Zeng XY; Ji L; Fan XJ; Li YQ; Hu XH; Qiu XQ; Yu HP
    Zhonghua Gan Zang Bing Za Zhi; 2010 Apr; 18(4):271-5. PubMed ID: 20460046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of XPC Lys939Gln polymorphism and melanoma susceptibility.
    Jiang W; Zhang H; Chen QW; Xie S
    J Eur Acad Dermatol Venereol; 2016 Aug; 30(8):1327-31. PubMed ID: 26551988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A 1:1 matched case-control study on the interaction between HBV, HCV infection and DNA repair gene XPC Ala499Val, Lys939Gln for primary hepatocellular carcinoma].
    Cai XL; Gao YH; Yu ZW; Wu ZQ; Zhou WP; Yang Y; Xu Y; Song SF; Chen SD
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Sep; 30(9):942-5. PubMed ID: 20193233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between polymorphisms of Xeroderma pigmentosum complementation group C gene (XPC) and susceptibility to schizophrenia.
    Taghipour N; Saadat I; Saadat M
    Gene; 2019 May; 695():99-100. PubMed ID: 30769138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleotide excision repair pathway genes and oral premalignant lesions.
    Wang Y; Spitz MR; Lee JJ; Huang M; Lippman SM; Wu X
    Clin Cancer Res; 2007 Jun; 13(12):3753-8. PubMed ID: 17575242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. XPC polymorphisms and lung cancer risk.
    Lee GY; Jang JS; Lee SY; Jeon HS; Kim KM; Choi JE; Park JM; Chae MH; Lee WK; Kam S; Kim IS; Lee JT; Jung TH; Park JY
    Int J Cancer; 2005 Jul; 115(5):807-13. PubMed ID: 15729698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.